Hydrochloric Acid → Trifluoroacetic acid

HRID 1506502노트

반응식

HRID 1506502 반응식
C1(C(=[N:14][CH:15]([CH2:21][CH2:22][C:23]2[CH:24]=[C:25]3[C:48](=[CH:49][CH:50]=2)[C:29]2=[N:30][O:31][C:32]([C:33]4[C:37]([C:38]([F:41])([F:40])[F:39])=[C:36]([C:42]5[CH:47]=[CH:46][CH:45]=[CH:44][CH:43]=5)[O:35][N:34]=4)=[C:28]2[CH2:27][CH2:26]3)[C:16]([O:18]CC)=[O:17])C2C=CC=CC=2)C=CC=CC=1.Cl.[OH-].[Na+].[C:54]([OH:60])([C:56]([F:59])([F:58])[F:57])=[O:55]>C(OCC)C.CO.O>[NH2:14][CH:15]([CH2:21][CH2:22][C:23]1[CH:24]=[C:25]2[C:48](=[CH:49][CH:50]=1)[C:29]1=[N:30][O:31][C:32]([C:33]3[C:37]([C:38]([F:39])([F:40])[F:41])=[C:36]([C:42]4[CH:43]=[CH:44][CH:45]=[CH:46][CH:47]=4)[O:35][N:34]=3)=[C:28]1[CH2:27][CH2:26]2)[C:16]([OH:18])=[O:17].[C:54]([OH:60])([C:56]([F:59])([F:58])[F:57])=[O:55]

참가 물질

9

반응물 4

HCID 313Hydrochloric AcidHCID 6422Trifluoroacetic acidHCID 14798Sodium HydroxideHCID 86669931Ethyl 2-(diphenylmethyleneamino)-4-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl)butanoate

생성물 2

HCID 6422Trifluoroacetic acid수율 30.6%HCID 671708432-Amino-4-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl)butanoic acid

시약·촉매·용매 3

HCID 887Methanol용매HCID 962Water용매HCID 3283Diethyl Ether용매

실험 절차

To a stirred solution of ethyl 2-(diphenylmethyleneamino)-4-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl)butanoate (Preparation 91A, 34 mg, 0.050 mmol) and water (0.025 mL) in diethyl ether (1.5 mL) was added 6 N aqueous HCl (50 μL, 0.300 mmol). The mixture was stirred at room temperature for 30 min. The ether layer was removed and the residue was mixed with MeOH (0.5 mL) and 2 N aqueous sodium hydroxide (0.5 mL, 1.000 mmol). After being stirred at room temperature for 30 min, the mixture was acidified with TFA to get a clear solution. Purification using reverse phase HPLC (Phenomenex Luna AXIA 5 u c18 30×100 mm, 10 min. run, solvent A: 10% MeOH: 90% H2O: 0.1% TFA, solvent B: 90% MeOH, 10% H2O, 0.1% TFA), concentration and lyophilization gave 2-amino-4-(3-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl)butanoic acid, TFA (10 mg, 0.015 mmol, 30.6% yield) as a white solid. The compound had an HPLC retention time=3.40 min. (condition C); LC/MS M+1=484.1; 1H NMR (400 MHz, MeOD) δ ppm 7.91 (1H, d, J=7.7 Hz), 7.78 (2H, d, J=8.1 Hz), 7.59-7.72 (3H, m), 7.33 (1H, s), 7.30 (1H, dd, J=8.0, 1.7 Hz), 4.00 (1H, t, J=6.3 Hz), 3.04-3.10 (4H, m), 2.74-2.95 (2H, m), 2.12-2.36 (2H, m).

후처리

  1. customThe ether layer was removed
  2. stirringAfter being stirred at room temperature for 30 min
  3. customto get a clear solution
  4. customPurification
  5. concentrationphase HPLC (Phenomenex Luna AXIA 5 u c18 30×100 mm, 10 min. run, solvent A: 10% MeOH: 90% H2O: 0.1% TFA, solvent B: 90% MeOH, 10% H2O, 0.1% TFA), concentration and lyophilization

출처 및 근거

ORD 기록
ord-787a32f877f34c9d9468897acc463898
출처 데이터셋
uspto-grants-2015_12
특허 번호
US09216972B2

반응 노트

불러오는 중…